Harry Cassin
Publisher and Editor
Andy Spalding
Senior Editor
Jessica Tillipman
Senior Editor
Bill Steinman
Senior Editor
Richard L. Cassin
Editor at Large
Elizabeth K. Spahn
Editor Emeritus
Cody Worthington
Contributing Editor
Julie DiMauro
Contributing Editor
Thomas Fox
Contributing Editor
Marc Alain Bohn
Contributing Editor
Bill Waite
Contributing Editor
Shruti J. Shah
Contributing Editor
Russell A. Stamets
Contributing Editor
Richard Bistrong
Contributing Editor
Eric Carlson
Contributing Editor
Last week’s $1.06 billion blockbuster resolution by Sweden’s Ericsson included disgorgement to the SEC of $540 million. By our count that’s the second biggest disgorgement ever ordered in an FCPA enforcement action.… Continue Reading
Stockholm-based Ericsson cracked our top ten list Friday with a $1 billion mega-settlement that landed at number two.… Continue Reading
Most of us, if we have any sense at all, harbor some healthy distrust of the world’s biggest companies. For good reason we fear the concentrated power of giant corporations. What, after all, is one person compared to the overwhelming might of Facebook, Walmart, or Exxon?… Continue Reading
The Office of the Israel’s Tax and Economic Prosecutor announced Monday that it has reached a Conditional Agreement with Teva Pharmaceuticals Industries Ltd. with respect to the bribery issues Teva resolved with U.S.… Continue Reading
The press in Israel reported this week that Aeronautics Ltd., one of the largest military drone manufactures in Israel, is being investigated for suspected bribery of a foreign public official.
If confirmed, the investigation into foreign bribery offenses would be the fourth in Israel.… Continue Reading
The U.S. Supreme Court Monday ruled 9-0 to limit the Securities and Exchange Commission’s legal authority to recover ill-gotten profits from defendants.
The Supreme Court in Kokesh v. SEC said the SEC’s use of the remedy known as disgorgement is subject to a five-year statute of limitations.… Continue Reading
Teva Pharmaceutical’s $519 million enforcement action last month included disgorgement to the SEC of $236 million — the second biggest FCPA disgorgement of all time.
Teva knocked Daimler off the top ten disgorgement list.… Continue Reading
Teva Pharmaceutical’s $519 million resolution Thursday landed fourth on our list of the ten biggest FCPA cases of all time. It’s the first time an Israeli company has appeared in the top ten.… Continue Reading
Teva Pharmaceuticals Industries Ltd. agreed Thursday with the DOJ and SEC to resolve FCPA violations through a deferred prosecution agreement and total payments of $519 million.
The $519 million settlement will rank fourth on our list of the ten biggest FCPA cases.… Continue Reading
Israel’s enforcement of its foreign bribery statute took years to get off the ground but it’s now going full speed ahead.
Last week we witnessed Israel’s first conviction under its foreign bribery statues that was recorded in the NIP case, which I reported here in November.… Continue Reading
Israel’s Teva Pharmaceutical said in a securities filing Tuesday it has reserved $520 million for an FCPA settlement.
Teva said it is now in “advanced discussions” with the DOJ and SEC.… Continue Reading
ProPublica ran an exposé this week about big bucks for doctors who promote products for drug companies.
A Nashville psychiatrist led the pack, earning more than $1 million during the past four years for promotional talks and consulting for seven drug companies.… Continue Reading
